0000890821 EX-FILING FEES 0000890821 2026-02-09 2026-02-09 0000890821 1 2026-02-09 2026-02-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-1

(Form Type)

 

Enveric Biosciences, Inc.

(Exact Name of Each Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

Security
Type
  Security
Class Title
  Fee
Calculation
or Carry
Forward Rule
  Amount
Registered (1)
   Proposed
Maximum
Offering
Price Per
Unit
   Maximum
Aggregate
Offering
Price
   Fee Rate   Amount of
Registration
Fee
 
Equity  Common Stock, par value $0.01 per share ("Common Stock"),underlying warrants to purchase Common Stock  Other   680,620    $2.70 (2)  $1,837,674.00    0.00013810   $253.78 
Total Offering Amounts        $1,837,674.00        $253.78 
Total Fees Previously Paid                   - 
Total Fee Offsets                   - 
Net Fee Due                  $253.78 

 

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the number of shares registered hereunder includes such additional number of shares of common stock, par value $0.01 per share (the “Common Stock”) of Enveric Biosciences, Inc. (the “Company”), as are required to prevent dilution resulting from a stock split, stock dividend or similar transaction.
   
(2) The offering price has been estimated solely for the purposes of the calculation of the registration fee. The offering price has been calculated in accordance with the manner described in paragraphs (c) and (h) of Rule 457 under the Securities Act and is based upon the average of high and low prices reported by the Nasdaq Capital Market on February 5, 2026, a date within five (5) business days prior to the date of the filing of this Registration Statement.

N/A